Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tracking the fate of adoptively transferred myeloid-derived suppressor cells in the primary breast tumor microenvironment
Authors
Keywords
Flow cytometry, Spleen, Breast tumors, Lung and intrathoracic tumors, Adoptive transfer, Metastatic tumors, Secondary lung tumors, T cells
Journal
PLoS One
Volume 13, Issue 4, Pages e0196040
Publisher
Public Library of Science (PLoS)
Online
2018-04-21
DOI
10.1371/journal.pone.0196040
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
- (2016) Vinit Kumar et al. TRENDS IN IMMUNOLOGY
- 64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET
- (2015) Christoph M. Griessinger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Origin and pharmacological modulation of tumor-associated regulatory dendritic cells
- (2014) Hua Zhong et al. INTERNATIONAL JOURNAL OF CANCER
- Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
- (2014) P. Sinha et al. JOURNAL OF IMMUNOLOGY
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- In Vivo Tracking of Th1 Cells by PET Reveals Quantitative and Temporal Distribution and Specific Homing in Lymphatic Tissue
- (2014) C. M. Griessinger et al. JOURNAL OF NUCLEAR MEDICINE
- Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
- (2014) Hong Qin et al. NATURE MEDICINE
- The Tumor Microenvironment Shapes Lineage, Transcriptional, and Functional Diversity of Infiltrating Myeloid Cells
- (2014) K. G. Elpek et al. Cancer Immunology Research
- The pre-metastatic niche: finding common ground
- (2013) Jaclyn Sceneay et al. CANCER AND METASTASIS REVIEWS
- Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
- (2013) Cristina Iclozan et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- l-glutamine is a key parameter in the immunosuppression phenomenon
- (2012) Ines Hammami et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Tumor-Derived Granulocyte-Macrophage Colony-Stimulating Factor Regulates Myeloid Inflammation and T Cell Immunity in Pancreatic Cancer
- (2012) Lauren J. Bayne et al. CANCER CELL
- Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
- (2012) Jaclyn Sceneay et al. CANCER RESEARCH
- Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy
- (2012) C. S. F. Wong et al. CANCER RESEARCH
- On the armament and appearances of human myeloid-derived suppressor cells
- (2012) Isabel Poschke et al. CLINICAL IMMUNOLOGY
- Myeloid cell diversification and complexity: an old concept with new turns in oncology
- (2011) Mariacristina Chioda et al. CANCER AND METASTASIS REVIEWS
- Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
- (2011) Je-In Youn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- "Microenvironmental contaminations" induced by fluorescent lipophilic dyes used for noninvasive in vitro and in vivo cell tracking
- (2010) F. Lassailly et al. BLOOD
- Myeloid-derived suppressor cell heterogeneity and subset definition
- (2010) Elisa Peranzoni et al. CURRENT OPINION IN IMMUNOLOGY
- The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity
- (2010) Je-In Youn et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Tumor-Induced Tolerance and Immune Suppression Depend on the C/EBPβ Transcription Factor
- (2010) Ilaria Marigo et al. IMMUNITY
- HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment
- (2010) Cesar A. Corzo et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Potential differentiation of tumor bearing mouse CD11b+Gr-1+ immature myeloid cells into both suppressor macrophages and immunostimulatory dendritic cells
- (2009) Yoshinori Narita et al. BIOMEDICAL RESEARCH-TOKYO
- GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
- (2009) Johanna K. Morales et al. BREAST CANCER RESEARCH AND TREATMENT
- Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF
- (2009) Luigi Dolcetti et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
- (2009) S. Ostrand-Rosenberg et al. JOURNAL OF IMMUNOLOGY
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models
- (2009) F. Shojaei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
- (2008) K. Movahedi et al. BLOOD
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapy
- (2008) C. Marcela Diaz-Montero et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Cell tracking with optical imaging
- (2008) Elizabeth J. Sutton et al. EUROPEAN RADIOLOGY
- Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
- (2008) Ilaria Marigo et al. IMMUNOLOGICAL REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started